The size of the compensation
You will receive a compensation for your participation in the drug research. The compensation is based on the minimum wage, the length of the study, and the mental and physical inconvenience you experience as a volunteer. For example: the longer the study takes and the more often blood is drawn, the higher your compensation will be. In general, the compensation lies between € 121 and € 227 per day. For some extra procedures, such as a gastroscopy or an eye examination, an additional compensation might apply. You will also receive a travel costs compensation for each occasion that you have to travel from your home to the research center and back. For the medical examination you will only receive a travel costs compensation. The kilometer allowance is € 0.19 per kilometer. The travel costs compensation is at least € 12 and at most € 160 per return journey.
Payment and taxes
After the follow-up examination, your participation in the study is completed. PRA will pay the compensation including the travel costs to your bank account within 30 days. The payment is a gross amount that the Dutch Tax and Customs Administration views as ‘income from work’. We report the payment to the Dutch Tax and Customs Administration and you will receive an annual statement from PRA. How much tax you will have to pay over this income depends on your personal situation. The travel costs of not always taxed. Therefore, please carefully file any public transport tickets or write down the distances travelled on your income tax form.
Compensation for time, mental and physical inconvenience
The compensation is solely a payment for the time you invest and the mental and physical inconvenience that you experience. Before a drug may be tested on volunteers, it has already been investigated for many years in the laboratory. Consequently, PRA's doctors and researchers are familiar with the drug and know about its effects and possible side effects. The research on volunteers only starts if the drug appears to be safe and proves effective. The medical ethics review committee also assesses a study to check that the risks involved are not too significant.